The Expert Consensus Guideline Series Treatment of Epilepsy

被引:102
作者
Karceski, Steven [1 ]
Morrell, Martha [1 ]
Carpenter, Daniel [2 ]
机构
[1] Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA
[2] Comprehens NeuroSci Inc, New York, NY 10032 USA
关键词
D O I
10.1006/ebeh.2001.0283
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Over the past decade, many new epilepsy treatments have been approved in the United States, promising better quality of life for many with epilepsy. However, clinicians must now choose among a growing number of treatment options and possible combinations. Randomized clinical trials (RCTs) form the basis for evidence-based decision making about best treatment options, but they rarely compare active therapies, making decisions difficult. When medical literature is lacking, expert opinion is helpful, but may contain potential biases. The expert consensus method is a new approach for statistically analyzing pooled opinion to minimize biases inherent in other systems of summarizing expert opinion. We used this method to analyze expert opinion on treatment of three epilepsy syndromes (idiopathic generalized epilepsy, symptomatic localization-related epilepsy, and symptomatic generalized epilepsy) and status epilepticus. For all three syndromes, the experts recommended the same general treatment strategy. As a first step, they recommend monotherapy. If this fails, a second monotherapy should be tried. Following this, the experts are split between additional trials of monotherapy and a combination of two therapies. If this fails, most agree the next step should be additional trials of two therapies, with less agreement as to the next best step after this. One exception to these recommendations is that the experts recommend an evaluation for epilepsy surgery after the third failed step for symptomatic localization-related epilepsies. The results of the expert survey were used to develop user-friendly treatment guidelines concerning overall treatment strategies and choice of specific medications for different syndromes and for status epilepticus. (C) 2001 Comprehensive NeuroScience, Inc.
引用
收藏
页码:A1 / A50
页数:50
相关论文
共 68 条
  • [1] Alexopoulos G S, 2001, Postgrad Med, VSpec No Pharmacotherapy, P1
  • [2] Allen MH, 2001, POSTGRAD MED, V110, P1
  • [3] Altshuler L L, 2001, Postgrad Med, P1
  • [4] GABAPENTIN (NEURONTIN) AS ADD-ON THERAPY IN PATIENTS WITH PARTIAL SEIZURES - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    ANHUT, H
    ASHMAN, P
    FEUERSTEIN, TJ
    SAUERMANN, W
    SAUNDERS, M
    SCHMIDT, B
    BAUER, G
    DEISENHAMMER, E
    KLINGLER, D
    MAMOLI, B
    GRAF, M
    DANTA, G
    BERKOVIC, S
    VAJDA, F
    BUCHANAN, N
    SCHAPEL, G
    BLACK, A
    BAJADA, S
    DEBARSY, T
    LATERRE, C
    VANZANDIJCKE, M
    MCLACHLAN, RS
    PURVES, SJ
    LEE, MA
    BRUNI, J
    GAWEL, M
    HOLTLARSEN, B
    WERDELIN, L
    DALBY, MA
    IIVANAINEN, MV
    GIROUD, M
    LECLERCQ, E
    REMY, C
    SALLOU, C
    RICHENS, A
    BILL, PLA
    [J]. EPILEPSIA, 1994, 35 (04) : 795 - 801
  • [5] [Anonymous], 1998, Postgrad Med, VSpec No, P1
  • [6] [Anonymous], 2000, Am J Ment Retard, V105, P159
  • [7] [Anonymous], 1996, J Clin Psychiatry
  • [8] [Anonymous], 1996, Journal of Clinical Psychiatry
  • [9] Brook R H, 1986, Int J Technol Assess Health Care, V2, P53
  • [10] Levetiracetam for partial seizures - Results of a double-blind, randomized clinical trial
    Cereghino, JJ
    Biton, V
    Abou-Khalil, B
    Dreifuss, F
    Gauer, LJ
    Leppik, I
    [J]. NEUROLOGY, 2000, 55 (02) : 236 - 242